SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001745020-23-000057
Filing Date
2023-10-31
Accepted
2023-10-31 16:13:33
Documents
12
Period of Report
2023-10-27
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K thrx-20231027.htm   iXBRL 8-K 27884
  Complete submission text file 0001745020-23-000057.txt   157416

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thrx-20231027.xsd EX-101.SCH 1895
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT thrx-20231027_lab.xml EX-101.LAB 24833
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thrx-20231027_pre.xml EX-101.PRE 13039
6 EXTRACTED XBRL INSTANCE DOCUMENT thrx-20231027_htm.xml XML 2817
Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Filer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40869 | Film No.: 231364680
SIC: 2834 Pharmaceutical Preparations